Sandra Guedj is a Business Unit Director and Head of Market Access with over 15 years of international experience in the pharmaceutical industry, specializing in oncology, cell and gene therapies, and vaccines. They currently lead Vaccines & Immune Therapies at AstraZeneca and are the founder of Majes, focusing on commercial operations and market access strategies. Previously, Sandra held various strategic roles at Novartis and A.T. Kearney, and worked in mergers and acquisitions at HSBC. Sandra has a Master of Business Administration from ESSEC Business School and has pursued advanced studies in International Healthcare Leadership at McGill University. They are passionate about innovation and healthcare systems transformation and thrive in multicultural environments.
This person is not in the org chart
This person is not in any teams
This person is not in any offices